PMV Pharmaceuticals, Inc. (PMVP) - Dilution Analysis
Visualizing historical and potential share dilution over time
Dilution Analysis
Risk Assessment Details
Summary
PMVP currently has 53.3M outstanding shares. with moderate dilution risk from 13.5M authorized shares representing 25.4% potential dilution. The company has minimally diluted shareholders by 3.9% over the past 2 years.
Share Structure Timeline
Historical Data Points
| Date | Event | Outstanding | Supply |
|---|---|---|---|
| May 12, 2026 |
10-Q filing | 53.3M shares outstanding |
53M | 14M |
| May 09, 2025 |
10-Q filing | 52.0M shares outstanding |
52M | 14M |
| Mar 03, 2025 |
10-K filing | 51.6M shares outstanding |
52M | 14M |
| Nov 20, 2024 |
S-3 filing: PMV Pharmaceuticals, Inc. is offering common stock, preferred stock, and debt securities, subscription rights, and purchase contracts, up to $200,000,000 in the aggregate. |
52M | 14M |
| Nov 07, 2024 |
10-Q filing | 51.6M shares outstanding |
52M | 14M |
| Aug 08, 2024 |
10-Q filing | 51.5M shares outstanding |
51M | 14M |
| May 09, 2024 |
10-Q filing | 51.4M shares outstanding |
51M | 14M |
| Feb 29, 2024 |
10-K filing | 48.0M shares outstanding |
48M | 14M |
| Nov 09, 2023 |
10-Q filing | 49.0M shares outstanding |
49M | 14M |
| Aug 09, 2023 |
10-Q filing | 45.8M shares outstanding |
46M | 14M |
| May 10, 2023 |
10-Q filing | 45.8M shares outstanding |
46M | 14M |
| Mar 01, 2023 |
10-K filing | 45.6M shares outstanding |
46M | 14M |
| Mar 01, 2023 |
POS AM filing: PMV Pharmaceuticals, Inc. may offer common stock, preferred stock, debt securities, warrants, subscription rights, purchase contracts and units in one or more offerings and in any combination for an aggregate offering amount of up to $200,000,000. |
46M | 14M |
| Nov 08, 2022 |
10-Q filing | 45.6M shares outstanding |
46M | 14M |
| Aug 09, 2022 |
10-Q filing | 45.6M shares outstanding |
46M | 14M |
| May 10, 2022 |
10-Q filing | 45.6M shares outstanding |
46M | 14M |
| Mar 01, 2022 |
10-K filing | 45.5M shares outstanding |
45M | 14M |
| Nov 12, 2021 |
10-Q filing | 45.4M shares outstanding |
45M | 14M |
| Aug 13, 2021 |
10-Q filing | 45.3M shares outstanding |
45M | 14M |
| May 14, 2021 |
10-Q filing | 45.0M shares outstanding |
45M | 14M |
| Mar 03, 2021 |
10-K filing | 44.8M shares outstanding |
45M | 14M |
| Nov 13, 2020 |
10-Q filing | 44.8M shares outstanding |
45M | 14M |
| Sep 24, 2020 |
S-1/A filing: This is an S-1/A filing for an initial public offering of common stock. It includes information about the company's Series C preferred stock financing, the number of shares to be outstanding after the offering, and the use of proceeds. |
26M | 14M |
| Sep 21, 2020 |
S-1/A filing: This is an S-1/A filing for an initial public offering of common stock, with a proposed offering of 7,350,000 shares and a total of 38,584,310 shares outstanding after the offering. It also details the issuance and sale of Series C convertible preferred stock in November 2019. |
26M | 7.4M |
| Sep 04, 2020 |
S-1 filing: This S-1 filing describes a proposed offering of common stock, details of a previous Series C preferred stock financing, and the company's financial data. |
140M | 0 |